专利检索 ap:("Targazyme, Inc.") AND inv:"Thomas E. Ichim" 第 1 页

1.

发明公开
Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase 审中-公开

公开(公告)号：US20230416681A9

公开(公告)日：2023-12-28

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , C12N5/00 , C12N5/0775 , C12N5/0789 , A61K35/17 , C12N5/0797 , A61K35/12

CPC分类号： C12N5/0638 , C12Y204/01065 , C12N5/0637 , C12N5/0006 , C12N5/0663 , C12N5/0647 , A61K35/17 , C12N5/0623 , A61K2035/124 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

2.

发明申请
Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase 审中-公开

公开(公告)号：US20190017023A1

公开(公告)日：2019-01-17

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , C12N5/00 , C12N5/0775 , C12N5/0789 , A61K35/17 , C12N5/0797 , A61K35/12

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

3.

发明授权
Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase 有权

公开(公告)号：US11976298B2

公开(公告)日：2024-05-07

申请号：US16135487

申请日：2018-09-19

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , A61K35/17 , C12N5/00 , C12N5/0775 , C12N5/0789 , C12N5/0797 , A61K35/12

CPC分类号： C12N5/0638 , A61K35/17 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12Y204/01065 , A61K35/12 , A61K2035/124 , C12N2501/70 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.

4.

发明公开
AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE 审中-公开

公开(公告)号：US20240271093A1

公开(公告)日：2024-08-15

申请号：US18629323

申请日：2024-04-08

申请人： Targazyme, Inc.

发明人： Stephen D. Wolpe , Leonard Miller , Lynnet Koh , Thomas E. Ichim

IPC分类号： C12N5/0783 , A61K35/12 , A61K35/17 , C12N5/00 , C12N5/0775 , C12N5/0789 , C12N5/0797

CPC分类号： C12N5/0638 , A61K35/17 , C12N5/0006 , C12N5/0623 , C12N5/0637 , C12N5/0647 , C12N5/0663 , C12Y204/01065 , A61K35/12 , A61K2035/124 , C12N2501/70 , C12N2501/724

摘要： Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.